Gleamer
- Company typePrivate
- Founded2017
- HeadquartersParis, France
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
Gleamer firmographics
Firmographics- Name
- Gleamer
- Legal name
- GLEAMER
- Website
- https://gleamer.ai
- Company type
- Private
- Founded year
- 2017
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Gleamer industry classification
Industry- Product category
- Radiology AI / Medical Imaging Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)
Keywords
Where Gleamer is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Gleamer business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Subscriptions: Annual recurring revenue from SaaS subscriptions to Gleamer Copilot platform and individual AI applications. Customers pay subscription fees for access to AI-powered radiology tools. ARR exceeded $30 million in 2026 prior to acquisition by RadNet, with over 90% CAGR from 2022-2025.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription pricing for hospitals and imaging groups |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Gleamer product offering
Product offeringCore offering
Gleamer develops and sells AI-powered clinical software for radiologists that detects fractures, chest pathologies, lung nodules, breast lesions, and neurological findings on X-ray, CT, MRI, and mammography images, automates musculoskeletal measurements, and generates structured radiology reports. Its Gleamer Copilot platform unifies these AI applications and integrates them into radiologist PACS/RIS workflows through the GleamerOS orchestration layer.
Product overview
Gleamer is a French medtech company (acquired by RadNet in March 2026) offering Gleamer Copilot, an all-in-one AI platform for radiology covering all major imaging modalities (X-ray, CT, MRI, Mammography). The portfolio comprises 11+ clinical AI applications organized in three tiers: Detection AI (BoneView, ChestView, BreastView, LungCT, BoneCT), Measurement AI (BoneMetrics, BoneAge), and Neuro MRI AI (Pixyl.Neuro.MS, Pixyl.Neuro.BV, LumbarMR). Reporting AI products (Voice, AutoReport) generate structured reports from AI findings. The entire ecosystem runs on GleamerOS, a cloud-native orchestration platform enabling deployment via a single Gateway with deep RIS/PACS integration via DICOM, HL7, and FHIR standards. Products are available as CE-marked (EU) and FDA 510(k)-cleared (US) Class II medical devices.
Differentiator
Problem solved
Functional benefit
Brands
- Gleamer Copilot: The all-in-one AI platform for radiology combining detection tools, smart measurements, and structured reporting
- GleamerOS
- BoneView
- ChestView
- BoneMetrics
- BoneAge
- LungCT
- BoneCT
- BreastView
- Pixyl.Neuro
- LumbarMR
- Voice
- AutoReport
Products and services
- Gleamer Copilot Unified AI platform that combines detection tools, smart measurements, and structured reporting seamlessly integrated into radiologist workflows across X-ray, CT, MRI, and mammography modalities.
- BoneView FDA 510(k)-cleared and CE-marked AI solution that detects fractures, dislocations, bone lesions, and effusions on radiographs with >99% NPV, reducing missed fractures by 30% and reading time by 36%.
- BoneMetrics FDA-cleared and CE-marked AI solution that automates 50+ musculoskeletal measurements including Cobb angles, HKA angles, leg length, shoulder, knee, and pelvic measurements, with 93.4% of measurements requiring no further adjustments.
- ChestView FDA-cleared and CE-marked AI solution that detects pneumothorax, consolidation, nodules, mediastinal masses, and pleural effusions on chest X-rays, increasing sensitivity by up to 50% for pneumothorax and reducing missed pneumothorax by 55%.
- BoneAge CE-marked AI solution that automates pediatric bone age assessment from hand X-rays using the Greulich & Pyle atlas method, achieving an MAE of 0.49 years (6 months) versus 0.72 years (9 months) for human readers.
- LungCT CE-marked AI solution that detects and characterizes pulmonary nodules on chest CT, achieving 43.3% fewer missed nodules versus unaided radiologists and 76% sensitivity for all nodules.
- BoneCT CE-marked AI solution that detects secondary bone lesions on CT scans for oncology staging, identifying bone metastases on spine, pelvis, and long bones with 67% sensitivity versus 56% for radiologists without AI.
- BreastView CE-marked AI mammography assistant that analyzes 2D and 3D mammograms to detect soft tissue lesions, masses, distortions, asymmetries, and microcalcifications with 85% sensitivity and 93% specificity for cancer detection.
- Pixyl.Neuro.MS FDA-cleared and CE-marked AI solution for multiple sclerosis on brain MRI that automatically detects, categorizes, and quantifies white-matter lesions on 3D FLAIR, with 97% sensitivity for detecting disease activity.
- Pixyl.Neuro.BV FDA-cleared and CE-marked AI solution that segments brain structures on 3D T1-weighted MRI, computes volumes, compares to a normative population, and highlights atrophy patterns for Alzheimer's disease and other dementias.
- LumbarMR AI solution for lumbar spine MRI that automatically detects and characterizes degenerative findings including endplate degeneration, disc herniation, compression fractures, spondylolisthesis, central canal stenosis, foraminal stenosis, and facet arthropathy.
- Voice AI-powered voice dictation and reporting assistant that listens to radiologist dictation, understands medical context, auto-fills indication, technique, and findings, and proposes smart impressions across custom templates.
- AutoReport AI reporting assistant that automatically generates structured radiology reports with AI findings, key measurements, and smart impressions, compatible with HL7, FHIR, and DICOM SR standards.
Quantifiable outcome
- Missed fractures decreased by 30% with AI assistance
- +6 more outcomes
Companies that use Gleamer
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles3 records
Gleamer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability9 records
Feature12 records
Gleamer partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, major and flagship.
- PhilipscoreVestre Viken Hospital Trust implemented Philips AI Manager with Philips Vue PACS, deploying Gleamer's BoneView as the first AI solution in routine clinical use. Demonstrates integration capabilities with Philips healthcare IT infrastructure.
- Google CloudcoreStrategic partnership where Google Cloud powers Gleamer's radiological AI platform, Gleamer Copilot. Leverages Google Cloud infrastructure including BigQuery, Vertex AI, and Med-PaLM for automated diagnostic report generation. Platform deployed in 2,500+ institutions across 45 countries processing 35 million examinations annually.
- France Imageries TerritoiresmajorStrategic partnership to deploy Gleamer Copilot nationwide across France Imageries Territoires imaging network. Major national deployment expanding Gleamer's presence in French healthcare market.
- Konica Minolta HealthcarecorePartnership to provide best-in-class AI-powered solution with Konica Minolta's portfolio of advanced X-ray systems. Combines Gleamer's AI detection capabilities with Konica Minolta's imaging hardware for integrated customer offerings.
- Siemens HealthineerscoreGleamer's BoneView available on Siemens Healthineers Digital Marketplace, enabling seamless integration with Siemens Healthineers PACS and imaging systems. Expands distribution through Siemens Healthineers global customer network.
- Vestre Viken Hospital TrustflagshipNorway's first hospital trust to integrate Philips AI Manager with Philips Vue PACS, deploying Gleamer's BoneView as first AI solution. Since August 2023, examined 74,000 patients, saving 594 days waiting time, preventing 13,800 emergency consultations, freeing 3,100 physician hours. Sets national blueprint for AI deployment in radiology.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Gleamer competitors and assessment
Company assessmentDirect peers
- Aidoc: Aidoc is a direct competitor offering a comprehensive AI platform for radiology covering multiple modalities and clinical workflows, with FDA-cleared applications across CT, X-ray, and MRI. It targets the same hospital and imaging center buyer base as Gleamer with a similar platform-plus-app strategy.
- Qure.ai: Qure.ai develops multi-modality radiology AI (chest X-ray, head CT, lung nodule, musculoskeletal) with strong presence in emerging and developed markets. It competes head-to-head with Gleamer in fracture, chest, and head CT detection products sold to hospitals and radiology groups.
- Lunit: Lunit is a publicly-traded Korean radiology AI company known for its chest X-ray (Lunit INSIGHT CXR) and mammography (Lunit INSIGHT MMG) products. It directly competes with Gleamer's ChestView and BreastView in the mammography and chest X-ray detection categories.
- Annalise.ai: Annalise.ai offers a comprehensive AI decision-support platform covering X-ray and CT findings across multiple anatomies, with broad modality coverage that mirrors Gleamer Copilot's horizontal strategy. It serves hospitals and radiology groups globally with a similar product breadth.
- Viz.ai: Viz.ai is a leading AI platform for time-sensitive radiology workflows, particularly stroke and cardiology, selling into the same hospital system buyer base as Gleamer. It represents a strong AI-native peer in adjacent clinical use cases within the radiology AI category.
- RapidAI: RapidAI provides AI-driven imaging analysis for stroke, aneurysm, and other time-sensitive conditions, with hospital enterprise sales. It overlaps with Gleamer's MRI/CT product strategy in neurovascular and shares the same hospital radiology buyer.
Broad incumbents
- Siemens Healthineers (AI-Rad Companion): Siemens Healthineers is both a Gleamer partner (Digital Marketplace) and a competitor via its AI-Rad Companion portfolio, which offers native radiology AI capabilities to its large installed base of imaging systems. It represents a broad incumbent with overlapping capabilities but a much wider portfolio.
- Philips (AI Manager / AI portfolio): Philips is both a Gleamer partner (AI Manager integration at Vestre Viken) and a competitor through its broader clinical AI portfolio tied to Vue PACS and imaging systems. It has the scale and distribution to bundle first-party AI offerings alongside Gleamer's solutions.
- GE HealthCare (Edison AI): GE HealthCare competes through its Edison AI platform and AI-powered imaging applications integrated with its large installed base of CT, MRI, and X-ray systems. It is a broad incumbent with the scale to bundle or replace third-party AI solutions like Gleamer's.
Emerging players
- Riverain Technologies: Riverain Technologies is a focused radiology AI company specializing in chest X-ray interpretation, directly competing with Gleamer's ChestView in the same clinical use case. It is a smaller, more focused player with partial modality overlap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Gleamer social profiles
Digital presenceGleamer compliance and trust
Trust signalCompliance12 records
Gleamer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gleamer leadership team
Management profileNumber of profiles
Profiles3 records
Gleamer subsidiaries and ownership
Company hierarchySubsidiaries2 records
Gleamer funding detail
Funding detailFunding overview
Funding rounds5 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gleamer M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gleamer
What does Gleamer do?
Gleamer develops and sells AI-powered clinical software for radiologists that detects fractures, chest pathologies, lung nodules, breast lesions, and neurological findings on X-ray, CT, MRI, and mammography images, automates musculoskeletal measurements, and generates structured radiology reports. Its Gleamer Copilot platform unifies these AI applications and integrates them into radiologist PACS/RIS workflows through the GleamerOS orchestration layer.
Is Gleamer a public or private company?
Gleamer is a private company. It is classified as corporate owned and is currently acquired.
When was Gleamer founded?
Gleamer was founded in 2017. It employs 51 to 100 people.
Where is Gleamer based?
Gleamer is headquartered in Paris, France, in the Europe region.
How does Gleamer make money?
One revenue line is on record: saaS Subscriptions.
Who are Gleamer's main competitors?
Direct peers on record are Aidoc, Qure.ai, Lunit, Annalise.ai, Viz.ai and RapidAI. Broad incumbents are Siemens Healthineers (AI-Rad Companion), Philips (AI Manager / AI portfolio) and GE HealthCare (Edison AI). Riverain Technologies is listed as an emerging player.
Does Gleamer have an API?
No public API is recorded for Gleamer.
What industry is Gleamer in?
Gleamer's product category is Radiology AI / Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 54151 and its SIC code is 3841.